In summary, this study provides more comprehensive evidence that CXCR4 antagonism can effectively correct WHIM-associated neutrophil and lymphocyte abnormalities in primary and secondary lymphoid organs in a mouse model of WHIM syndrome. This evidence concerns the gene CXCR4 and WHIM syndrome.